According to a study published in the journal Diabetes, a novel ready-to-use liquid stable glucagon was effective in maintaining euglycemia (normal levels of blood sugar) during prolonged, continuous, intense aerobic exercise in patients with type 1 diabetes. Researchers conducted a phase 2 randomized, placebo-controlled, double-blind, clinical research center (CRC) crossover stage, followed by a 12-week 3-arm parallel Outpatient stage.
Mauden Maytre
Etransport4524
Augustuscapital
Center For Vein Wellness
W88couytinkhong
Infygain Technologies
The Maids
Iwinclub68mobi
Easybuild
Resedahighschool